• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物剂型在小肠中的转运。

Transit of pharmaceutical dosage forms through the small intestine.

作者信息

Davis S S, Hardy J G, Fara J W

出版信息

Gut. 1986 Aug;27(8):886-92. doi: 10.1136/gut.27.8.886.

DOI:10.1136/gut.27.8.886
PMID:3732895
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1433369/
Abstract

The gastrointestinal transit of pharmaceutical dosage forms has been measured in 201 studies in normal subjects using gamma scintigraphy. Solutions, small pellets, and single units (matrix tablets and osmotic pumps) were administered with different amounts of food in the stomach, ranging from fasted state to heavy breakfast. Gastric emptying was affected by the nature of the dosage form and the presence of food in the stomach. Solutions and pellets were emptied even when the stomach was in the digestive mode, while single units were retained for long periods of time, depending on the size of the meal. In contrast, measured intestinal transit times were independent of the dosage form and fed state. The small intestinal transit time of about three hours (mean +/- 1 h SEM) has implications for the design of dosage forms for the sustained release of drugs in specific positions in the gastrointestinal tract.

摘要

在201项针对正常受试者的研究中,采用γ闪烁扫描法测定了药物剂型的胃肠道转运情况。溶液剂、小丸剂和单一单元制剂(骨架片和渗透泵)在胃中与不同量的食物一起给药,范围从禁食状态到丰盛早餐。胃排空受剂型性质和胃中食物存在情况的影响。即使胃处于消化模式,溶液剂和小丸剂也会排空,而单一单元制剂会根据餐量大小长时间滞留。相比之下,测得的肠道转运时间与剂型和进食状态无关。约三小时(平均值±1小时标准误)的小肠转运时间对胃肠道特定部位药物缓释剂型的设计具有启示意义。

相似文献

1
Transit of pharmaceutical dosage forms through the small intestine.药物剂型在小肠中的转运。
Gut. 1986 Aug;27(8):886-92. doi: 10.1136/gut.27.8.886.
2
Meal-induced acceleration of tablet transit through the human small intestine.进餐引起的片剂在人体小肠内转运加速。
Pharm Res. 2009 Feb;26(2):356-60. doi: 10.1007/s11095-008-9749-2. Epub 2008 Nov 4.
3
Analysis of small intestinal transit and colon arrival times of non-disintegrating tablets administered in the fasted state.空腹状态下服用的不崩解片剂的小肠转运时间和结肠到达时间分析。
Eur J Pharm Sci. 2015 Jul 30;75:131-41. doi: 10.1016/j.ejps.2015.03.001. Epub 2015 Mar 11.
4
Gastroretentive dosage forms.胃滞留剂型
Crit Rev Ther Drug Carrier Syst. 1993;10(2):143-95.
5
Effects of Diurnal Variation and Food on Gastrointestinal Transit of In-Labeled Hydrogel Matrix Extended-Release Tablets and Tc-Labeled Pellets in Humans.人体标记水凝胶基质控释片和 Tc 标记微丸的胃肠道转运的昼夜变化和食物影响。
J Pharm Sci. 2020 Feb;109(2):1020-1025. doi: 10.1016/j.xphs.2019.09.025. Epub 2019 Oct 7.
6
Gastrointestinal transit of model mini-tablet controlled release oral dosage forms in fasted human volunteers.模型微型片剂控释口服剂型在空腹人类志愿者体内的胃肠道转运。
J Pharm Pharmacol. 2007 Jul;59(7):941-5. doi: 10.1211/jpp.59.7.0005.
7
Gastric emptying of large single unit dosage forms.大的单一单位剂型的胃排空
J Pharm Pharmacol. 1988 Mar;40(3):205-7. doi: 10.1111/j.2042-7158.1988.tb05220.x.
8
Gastric retentive dosage forms: a review.胃滞留剂型:综述
Crit Rev Ther Drug Carrier Syst. 2003;20(6):459-97. doi: 10.1615/critrevtherdrugcarriersyst.v20.i6.30.
9
The effect of polyethylene glycol 400 on gastrointestinal transit: implications for the formulation of poorly-water soluble drugs.聚乙二醇400对胃肠道转运的影响:对难溶性药物制剂的启示。
Pharm Res. 2001 Aug;18(8):1146-50. doi: 10.1023/a:1010927026837.
10
Understanding the in vivo performance of enteric coated tablets using an in vitro-in silico-in vivo approach: case example diclofenac.采用体内-体外-体内模拟方法理解肠溶片剂的体内性能:案例分析双氯芬酸。
Eur J Pharm Biopharm. 2013 Nov;85(3 Pt B):1337-47. doi: 10.1016/j.ejpb.2013.09.009. Epub 2013 Sep 18.

引用本文的文献

1
Encapsulation of Green Tea Extract (GTE) in Nanoliposome and Assessment of Its Characterization and In Vitro Release Study of GTE.绿茶提取物(GTE)在纳米脂质体中的包封及其表征评估和GTE的体外释放研究
Food Sci Nutr. 2025 Aug 16;13(8):e70781. doi: 10.1002/fsn3.70781. eCollection 2025 Aug.
2
Development of a Multi-Purpose Comprehensive Physiologically Based Pharmacokinetic Model for Crizotinib: An Example Application in Bioequivalence Assessment between Oral Solution and Granules in Pediatric Subjects.克唑替尼多用途综合生理药代动力学模型的开发:儿科受试者口服溶液与颗粒剂生物等效性评估的示例应用
AAPS J. 2025 Jul 28;27(5):126. doi: 10.1208/s12248-025-01106-w.
3
The Development of an Age-Appropriate Fixed Dose Combination for Tuberculosis Using Physiologically-Based Pharmacokinetic Modeling (PBBM) and Risk Assessment.使用基于生理学的药代动力学模型(PBBM)和风险评估开发适合年龄的结核病固定剂量复方制剂。
Pharmaceutics. 2024 Dec 12;16(12):1587. doi: 10.3390/pharmaceutics16121587.
4
Physiologically Based Biopharmaceutics Modeling Coupled with Biopredictive Dissolution in Development of Bioequivalent Formulation for Mesalamine Enteric Coated Tablet: A Tough Nut to Crack.基于生理的生物药剂学建模结合生物预测溶出度在美沙拉嗪肠溶片生物等效制剂开发中的应用:一项棘手的任务。
AAPS PharmSciTech. 2024 Dec 2;26(1):1. doi: 10.1208/s12249-024-02990-9.
5
Delving the depths of 'terra incognita' in the human intestine - the small intestinal microbiota.探索人体肠道中“未知领域”的深处——小肠微生物群。
Nat Rev Gastroenterol Hepatol. 2025 Jan;22(1):71-81. doi: 10.1038/s41575-024-01000-4. Epub 2024 Oct 23.
6
Advances in Modeling Approaches for Oral Drug Delivery: Artificial Intelligence, Physiologically-Based Pharmacokinetics, and First-Principles Models.口服药物递送建模方法的进展:人工智能、基于生理的药代动力学和第一性原理模型
Pharmaceutics. 2024 Jul 24;16(8):978. doi: 10.3390/pharmaceutics16080978.
7
A Semi-Mechanistic Physiologically Based Biopharmaceutics Model to Describe Complex and Saturable Absorption of Metformin: Justification of Dissolution Specifications for Extended Release Formulation.半机械论生理基于生物药剂学模型描述二甲双胍的复杂和饱和吸收:为缓释制剂的溶出度规格提供依据。
AAPS PharmSciTech. 2024 Aug 21;25(7):193. doi: 10.1208/s12249-024-02904-9.
8
Colon Drug Delivery Systems Based on Swellable and Microbially Degradable High-Methoxyl Pectin: Coating Process and In Vitro Performance.基于可溶胀和微生物可降解高甲氧基果胶的结肠给药系统:包衣工艺及体外性能
Pharmaceutics. 2024 Apr 7;16(4):508. doi: 10.3390/pharmaceutics16040508.
9
N-Succinylaspartic-Acid-Conjugated Riluzole Is a Safe and Potent Colon-Targeted Prodrug of Riluzole against DNBS-Induced Rat Colitis.N-琥珀酰天冬氨酸共轭利鲁唑是一种安全有效的利鲁唑结肠靶向前药,可用于治疗二硝基苯磺酸诱导的大鼠结肠炎。
Pharmaceutics. 2023 Nov 16;15(11):2638. doi: 10.3390/pharmaceutics15112638.
10
Model-based optimization of controlled release formulation of levodopa for Parkinson's disease.基于模型的帕金森病左旋多巴控释制剂的优化。
Sci Rep. 2023 Sep 22;13(1):15869. doi: 10.1038/s41598-023-42878-5.

本文引用的文献

1
Transit of a meal through the stomach, small intestine, and colon in normal subjects and its role in the pathogenesis of diarrhea.正常受试者进餐通过胃、小肠和结肠的过程及其在腹泻发病机制中的作用。
Gastroenterology. 1980 Dec;79(6):1276-82.
2
The effect of specific gravity and eating on gastric emptying of slow-release capsules.比重和饮食对缓释胶囊胃排空的影响。
N Engl J Med. 1981 May 28;304(22):1365-6. doi: 10.1056/NEJM198105283042220.
3
Is the transit time of a meal through the small intestine related to the rate at which it leaves the stomach?一餐食物通过小肠的时间与它离开胃的速度有关吗?
Gut. 1982 Oct;23(10):824-8. doi: 10.1136/gut.23.10.824.
4
Relationship of motility to flow of contents in the human small intestine.人体小肠中蠕动与内容物流动的关系。
Gastroenterology. 1982 Apr;82(4):701-6.
5
Gastric emptying as a determinant of the oral glucose tolerance test.胃排空作为口服葡萄糖耐量试验的一个决定因素。
Gastroenterology. 1982 Jan;82(1):51-5.
6
Irritable bowel syndrome: relationship of disorders in the transit of a single solid meal to symptom patterns.肠易激综合征:单次固体食物转运障碍与症状模式的关系。
Gut. 1983 May;24(5):405-11. doi: 10.1136/gut.24.5.405.
7
Measurement of intestinal progression of a meal and its residues in normal subjects and patients with functional diarrhoea by a dual isotope technique.
Gut. 1984 Jul;25(7):728-31. doi: 10.1136/gut.25.7.728.
8
Small bowel transit time of food in man: measurement, regulation and possible importance.人体食物在小肠中的通过时间:测量、调节及可能的重要性。
Scand J Gastroenterol Suppl. 1984;96:77-85.
9
Scintigraphic determination of small intestinal transit time: comparison with the hydrogen breath technique.闪烁扫描法测定小肠通过时间:与氢呼气试验的比较
Gastroenterology. 1984 Apr;86(4):714-20.
10
Oral domperidone: double blind comparison with placebo in irritable bowel syndrome.口服多潘立酮:与安慰剂治疗肠易激综合征的双盲对照研究
Gut. 1983 Dec;24(12):1135-40. doi: 10.1136/gut.24.12.1135.